http://orcid.org/0000-0002-7995-3626
Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Johan Westin, Magdalena Ydreborg, Christian Kampmann, Rune Wejstål & Ola Weiland. (2023) Dismal prognosis for cirrhotic patients with hepatitis C after initial failure of direct acting anti-virals, but salvage therapy may be life-saving. Infectious Diseases 0:0, pages 1-8.
Read now
Read now
Charlotta Millbourn, Charlotte Lybeck, Afrodite Psaros Einberg, Margareta Nordin, Gudrun Lindh, Ingegerd Hökeberg, Hans Fredlund, Björn Fischler, Helena Fadl, Ann-Sofi Duberg & Karin Lindahl. (2020) Anti-HCV prevalence and risk factor-based screening for hepatitis C in pregnant women and their partners in Sweden. Infectious Diseases 52:11, pages 776-785.
Read now
Read now
Jaran Eriksen, Christina Carlander, Jan Albert, Leo Flamholc, Magnus Gisslén, Lars Navér, Veronica Svedhem, Aylin Yilmaz & Anders Sönnerborg. (2020) Antiretroviral treatment for HIV infection: Swedish recommendations 2019. Infectious Diseases 52:5, pages 295-329.
Read now
Read now
H. Taflin, L. Hafström, E. Holmberg, M. Castedal & P. Lindnér. (2019) The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver disease. Scandinavian Journal of Gastroenterology 54:6, pages 746-752.
Read now
Read now
Vasily Isakov, Vladimir Chulanov, Dzhamal Abdurakhmanov, Eduard Burnevich, Elena Nurmukhametova, Galina Kozhevnikova, Natalya Gankina, Sergey Zhuravel, Svetlana Romanova, Robert H. Hyland, Sophia Lu, Evguenia S. Svarovskaia, John McNally, Diana M. Brainard, Vladimir Ivashkin, Vyacheslav Morozov, Igor Bakulin, Martin Lagging, Konstantin Zhdanov & Ola Weiland. (2019) Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden. Infectious Diseases 51:2, pages 131-139.
Read now
Read now
Articles from other publishers (10)
E. Kågström, A. Lannergård, J. El Khosht, P. Lörelius, J. Månflod & S. Strömdahl. (2023) Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden. Harm Reduction Journal 20:1.
Crossref
Crossref
Oskar Ljungquist, Jon Olinder, Jonas Tverring, Charlott Kjölvmark & Gustav Torisson. (2023) Agreement and reliability of hepatic transient elastography in patients with chronic hepatitis C: A cross‐sectional test–retest study. Health Science Reports 6:4.
Crossref
Crossref
Tomoya Fukuoka, Kazuhiko Bessho, Satoyo Hosono, Daiki Abukawa, Tatsuki Mizuochi, Koichi Ito, Jun Murakami, Hideo Tanaka, Yoko Miyoshi, Tomoko Takano & Hitoshi Tajiri. (2022) The impact of treatment on the psychological burden of mothers of children with chronic hepatitis C virus infection: a multicenter, questionnaire survey. Scientific Reports 12:1.
Crossref
Crossref
Soledad Colombe, Maria Axelsson, Soo Aleman, Ann-Sofi Duberg, Josefine Lundberg Ederth & Viktor Dahl. (2022) Monitoring the progress towards the elimination of hepatitis B and C in Sweden: estimation of core indicators for 2015 and 2018. BMC Infectious Diseases 22:1.
Crossref
Crossref
Kiarash Keyvan, Mahmoud Reza Sohrabi & Fereshteh Motiee. (2022) An intelligent approach based on hybrid of principal component analysis-fuzzy inference system-adaptive neuro-fuzzy inference system for the simultaneous spectrophotometric determination of sofosbuvir and velpatasvir as antiviral drugs in pharmaceutical formulation and urine sample. Chemometrics and Intelligent Laboratory Systems 220, pages 104473.
Crossref
Crossref
Patricio E. Ray, Asha Moudgil & Aditi Sinha. 2022. Pediatric Nephrology. Pediatric Nephrology
707
733
.
Patricio E. Ray, Asha Moudgil & Aditi Sinha. 2020. Pediatric Nephrology. Pediatric Nephrology
1
28
.
Giuseppe Indolfi, Björn Fischler, Regino P. Gonzalez-Peralta, Mirta Ciocca, Gilda Porta, Mohan Neelam, Mohamed El-Guindi, Deirdre Kelly, Yen-Hsuan Ni, Anupan Sibal, Daniel H. Leung & Mei Hwei Chang. (2020) Comparison of Recommendations for Treatment of Chronic Hepatitis C Virus Infection in Children and Adolescents: A Position Paper of the Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology & Nutrition 70:5, pages 711-717.
Crossref
Crossref
Kristina Nyström, Jesper Waldenström, Ka-Wei Tang & Martin Lagging. (2019) Ribavirin: pharmacology, multiple modes of action and possible future perspectives. Future Virology 14:3, pages 153-160.
Crossref
Crossref
Malgorzata Pawlowska, Malgorzata Sobolewska-Pilarczyk & Krzysztof Domagalski. (2018) Hepatitis C virus infection in children in the era of direct-acting antiviral. World Journal of Gastroenterology 24:24, pages 2555-2566.
Crossref
Crossref